In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Andrea González-HernándezFacultad de Medicina, Universidad de Málaga (UMA), 29071 Malaga, Spain.
Beatriz Martínez-GálvezServicio de Oncología Médica, Hospital Virgen de la Victoria, Grupo B-05 Instituto de Investigación Biomédica de Málaga-Plataforma BIONAND (IBIMA-Plataforma Bionand), 29010 Malaga, Spain.ORCID 0000-0001-5664-5535 Felipe Vaca PaniaguaLaboratorio Nacional en Salud: Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Educación Superior Iztacala, Tlalnepantla 54090, Mexico.
Isabel BarragánServicio de Oncología Médica, Hospital Virgen de la Victoria, Grupo B-05 Instituto de Investigación Biomédica de Málaga-Plataforma BIONAND (IBIMA-Plataforma Bionand), 29010 Malaga, Spain.
Elisabeth Pérez-RuizServicio de Oncología Médica, Hospital Regional de Málaga, Grupo B-05 Instituto de Investigación Biomédica de Málaga-Plataforma BIONAND (IBIMA-Plataforma Bionand), 29010 Malaga, Spain.ORCID 0000-0001-7204-0800 José Carlos BenitezServicio de Oncología Médica, Hospital Virgen de la Victoria, Grupo B-05 Instituto de Investigación Biomédica de Málaga-Plataforma BIONAND (IBIMA-Plataforma Bionand), 29010 Malaga, Spain.
Antonio Rueda-DominguezServicio de Oncología Médica, Hospital Virgen de la Victoria, Grupo B-05 Instituto de Investigación Biomédica de Málaga-Plataforma BIONAND (IBIMA-Plataforma Bionand), 29010 Malaga, Spain.
Javier OliverServicio de Oncología Médica, Hospital Virgen de la Victoria, Grupo B-05 Instituto de Investigación Biomédica de Málaga-Plataforma BIONAND (IBIMA-Plataforma Bionand), 29010 Malaga, Spain.ORCID 0000-0002-8073-4711 Funding
Consejería de Economía, Conocimiento, Empresas y Universidad PAIDI P21-01002
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
adverse eventsbiomarkersIL7 polymorphismimmunotherapynon-small cell lung cancerpersonalized medicinepharmacogenetics
Identifiers
PMID41753174
PMCPMC12941508
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390